Seroatlas · Human Serome Atlas

BPGM

Bisphosphoglycerate mutase

Also known as: PMGE_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P07738
Gene
BPGM
Ensembl
ENSG00000172331
Chromosome
7
Canonical length
259 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Nucleoli,Nucleoli rim
Quaternary structure
Homodimer

OverviewNCBI Gene

2,3-diphosphoglycerate (2,3-DPG) is a small molecule found at high concentrations in red blood cells where it binds to and decreases the oxygen affinity of hemoglobin. This gene encodes a multifunctional enzyme that catalyzes 2,3-DPG synthesis via its synthetase activity, and 2,3-DPG degradation via its phosphatase activity. The enzyme also has phosphoglycerate phosphomutase activity. Deficiency of this enzyme increases the affinity of cells for oxygen. Mutations in this gene result in hemolytic anemia. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Sep 2009]

Canonical amino-acid sequenceUniProt

259 residues, UniProt reviewed canonical sequence.

>P07738|BPGM
     1  MSKYKLIMLR HGEGAWNKEN RFCSWVDQKL NSEGMEEARN CGKQLKALNF EFDLVFTSVL
    61  NRSIHTAWLI LEELGQEWVP VESSWRLNER HYGALIGLNR EQMALNHGEE QVRLWRRSYN
   121  VTPPPIEESH PYYQEIYNDR RYKVCDVPLD QLPRSESLKD VLERLLPYWN ERIAPEVLRG
   181  KTILISAHGN SSRALLKHLE GISDEDIINI TLPTGVPILL ELDENLRAVG PHQFLGDQEA
   241  IQAAIKKVED QGKVKQAKK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against BPGM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.23
Highest tissue expression
82 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 82 nTPM
  • placenta: 44 nTPM
  • urinary bladder: 37 nTPM
  • skeletal muscle: 35 nTPM
  • parathyroid gland: 33 nTPM
  • kidney: 33 nTPM

Single-cell type

  • syncytiotrophoblasts: 559 nCPM
  • oocytes: 484 nCPM
  • erythrocytes: 313 nCPM
  • epididymal clear cells: 63 nCPM
  • megakaryocytes: 62 nCPM
  • schwann cells: 59 nCPM

Immune cell

  • basophil: 61 nTPM
  • eosinophil: 49 nTPM
  • neutrophil: 30 nTPM
  • total PBMC: 24 nTPM
  • gdT-cell: 23 nTPM
  • non-classical monocyte: 23 nTPM

Brain region

  • spinal cord: 20 nTPM
  • hypothalamus: 18 nTPM
  • white matter: 17 nTPM
  • pons: 17 nTPM
  • medulla oblongata: 16 nTPM
  • cerebellum: 16 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about BPGM.

Disease | AllUniProt

Conditions BPGM is implicated in, by any mechanism.

Disease | GeneticClinVar

4 pathogenic / likely-pathogenic of 60 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1
gnomAD pLI
0.02
gnomAD missense Z
0.7
DepMap mean gene effect
0.05
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of BPGM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads BPGM as an antibody target. Whether an autoantibody or antibody against BPGM could matter depends on whether native BPGM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

BPGM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label BPGM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/BPGM. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...